Cardiovascular Comorbidities in COVID-19: Comprehensive Analysis of Key Topics.

Cardiovascular Comorbidities in COVID-19: Comprehensive Analysis of Key Topics.

Publication date: Jul 24, 2024

The interrelation between COVID-19 and various cardiovascular and metabolic disorders has been a critical area of study. There is a growing need to understand how comorbidities such as cardiovascular diseases (CVDs) and metabolic disorders affect the risk and severity of COVID-19. The objective of this study is to systematically analyze the association between COVID-19 and cardiovascular and metabolic disorders. The focus is on comorbidity, examining the roles of CVDs such as embolism, thrombosis, hypertension, and heart failure, as well as metabolic disorders such as disorders of glucose and iron metabolism. Our study involved a systematic search in PubMed for literature published from 2000 to 2022. We established 2 databases: one for COVID-19-related articles and another for CVD-related articles, ensuring all were peer-reviewed. In terms of data analysis, statistical methods were applied to compare the frequency and relevance of MeSH (Medical Subject Headings) terms between the 2 databases. This involved analyzing the differences and ratios in the usage of these terms and employing statistical tests to determine their significance in relation to key CVDs within the COVID-19 research context. The study revealed that “Cardiovascular Diseases” and “Nutritional and Metabolic Diseases” were highly relevant as level 1 Medical Subject Headings descriptors in COVID-19 comorbidity research. Detailed analysis at level 2 and level 3 showed “Vascular Disease” and “Heart Disease” as prominent descriptors under CVDs. Significantly, “Glucose Metabolism Disorders” were frequently associated with COVID-19 comorbidities such as embolism, thrombosis, and heart failure. Furthermore, iron deficiency (ID) was notably different in its occurrence between COVID-19 and CVD articles, underlining its significance in the context of COVID-19 comorbidities. Statistical analysis underscored these differences, highlighting the importance of both glucose and iron metabolism disorders in COVID-19 research. This work lays the foundation for future research that utilizes a knowledge-based approach to elucidate the intricate relationships between these conditions, aiming to develop more effective health care strategies and interventions in the face of ongoing pandemic challenges.

Concepts Keywords
Cardiovascular cardiovascular diseases
Covid COVID-19
Glucose effective
Pandemic embolism
Research embolism and thrombosis
glucose
heart failure
hyperglycemia
hypertension
iron metabolism disorders
MeSH
metabolic disorders
nutritional
thrombosis
vascular disease

Semantics

Type Source Name
disease MESH COVID-19
disease MESH cardiovascular diseases
disease MESH comorbidity
disease MESH embolism
disease MESH thrombosis
disease MESH hypertension
disease MESH heart failure
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Iron
pathway REACTOME Metabolism
disease VO frequency
disease MESH Nutritional and Metabolic Diseases
disease MESH Vascular Disease
disease MESH Heart Disease
disease MESH Glucose Metabolism Disorders
disease MESH iron deficiency
disease MESH iron metabolism disorders
disease VO effective
disease MESH Long Covid
disease MESH embolism and thrombosis
disease MESH hyperglycemia

Original Article

(Visited 1 times, 1 visits today)